Emerging Biomarkers and Targeted Therapies in Feline Mammary Carcinoma

Feline mammary carcinoma (FMC) is a common aggressive malignancy with a low survival rate that lacks viable therapeutic options beyond mastectomy. Recently, increasing efforts have been made to understand the molecular mechanisms underlying FMC development, using the knowledge gained from studies on...

Descripción completa

Detalles Bibliográficos
Autores principales: Gameiro, Andreia, Urbano, Ana Catarina, Ferreira, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402877/
https://www.ncbi.nlm.nih.gov/pubmed/34437486
http://dx.doi.org/10.3390/vetsci8080164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402877/
https://www.ncbi.nlm.nih.gov/pubmed/34437486
http://dx.doi.org/10.3390/vetsci8080164

Ejemplares similares